PD treatment exposes the peritoneal membrane to bioincompatible dialysis fluids that cause fibrosis and neoangiogenesis, or a progressive increase in the number of capillaries, the researchers point ...
LUND, Sweden, June 04, 2026--(BUSINESS WIRE)--Triomed AB today announced positive results from a prospective, multicenter, randomized, crossover study evaluating steady concentration peritoneal ...
A common genetic variant predicted poor outcomes from peritoneal dialysis, suggesting a potential factor for patient selection and treatment, researchers found. Variants in AQP1, the gene that encodes ...
Steady concentration PD with the Carry Life UF system increased ultrafiltration nearly threefold and sodium removal nearly tenfold vs 2.5% dextrose CAPD, while improving glucose efficiency and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results